Abstract
Recently, CP7_E2alf (Suvaxyn®CSF Marker), a live marker vaccine against classical swine fever virus, was licensed through the European Medicines Agency. For application of such a genetically engineered virus under field conditions, knowledge about its genetic stability is essential. Here, we report on stability studies that were conducted to assess and compare the mutation rate of CP7_E2alf in vitro and in vivo. Sequence analyses upon passaging confirmed the high stability of CP7_E2alf, and no recombination events were observed in the experimental setup. The data obtained in this study confirm the genetic stability of CP7_E2alf as an important safety component.
References
Aebischer A, Müller M, Hofmann MA (2013) Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies. Vet Microbiol 161:274–285
Backer JA, Hagenaars TJ, van Roermund HJ, de Jong MC (2009) Modelling the effectiveness and risks of vaccination strategies to control classical swine fever epidemics. J R Soc Interface 6:849–861
Beer M, Reimann I, Hoffmann B, Depner K (2007) Novel marker vaccines against classical swine fever. Vaccine 25:5665–5670
Blome S, Meindl-Böhmer A, Loeffen W, Thuer B, Moennig V (2006) Assessment of classical swine fever diagnostics and vaccine performance. Rev Sci Tech 25:1025–1038
Blome S, Gabriel C, Staubach C, Leifer I, Strebelow G, Beer M (2011) Genetic differentiation of infected from vaccinated animals after implementation of an emergency vaccination strategy against classical swine fever in wild boar. Vet Microbiol 153:373–376
Blome S, Aebischer A, Lange E, Hofmann M, Leifer I, Loeffen W, Koenen F, Beer M (2012) Comparative evaluation of live marker vaccine candidates “CP7_E2alf” and “flc11” along with C-strain “Riems” after oral vaccination. Vet Microbiol 158:42–59
Blome S, Gabriel C, Schmeiser S, Meyer D, Meindl-Böhmer A, Koenen F, Beer M (2014) Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes. Vet Microbiol 169:8–17
Chen Y, Chen YF (2014) Extensive homologous recombination in classical swine fever virus: A re-evaluation of homologous recombination events in the strain AF407339. Saudi J Biol Sci 21:311–316
Dong XN, Chen YH (2007) Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine 25:205–230
Dräger C, Petrov A, Beer M, Teifke JP, Blome S (2015) Classical swine fever virus marker vaccine strain CP7_E2alf: shedding and dissemination studies in boars. Vaccine 33:3100–3103
Eble PL, Geurts Y, Quak S, Moonen-Leusen HW, Blome S, Hofmann MA, Koenen F, Beer M, Loeffen WL (2013) Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics. Vet Microbiol 162:437–446
Edwards S, Fukusho A, Lefevre PC, Lipowski A, Pejsak Z, Roehe P, Westergaard J (2000) Classical swine fever: the global situation. Vet Microbiol 73:103–119
Gabriel C, Blome S, Urniza A, Juanola S, Koenen F, Beer M (2012) Towards licensing of CP7_E2alf as marker vaccine against classical swine fever—duration of immunity. Vaccine 30:2928–2936
Gallei A, Pankraz A, Thiel HJ, Becher P (2004) RNA recombination in vivo in the absence of viral replication. J Virol 78:6271–6281
Gallei A, Orlich M, Thiel HJ, Becher P (2005) Noncytopathogenic pestivirus strains generated by nonhomologous RNA recombination: alterations in the NS4A/NS4B coding region. J Virol 79:14261–14270
Gallei A, Rümenapf T, Thiel HJ, Becher P (2005) Characterization of helper virus-independent cytopathogenic classical swine fever virus generated by an in vivo RNA recombination system. J Virol 79:2440–2448
He CQ, Ding NZ, Chen JG, Li YL (2007) Evidence of natural recombination in classical swine fever virus. Virus Res 126:179–185
Ji W, Niu DD, Si HL, Ding NZ, He CQ (2014) Vaccination influences the evolution of classical swine fever virus. Infect Genet Evol 25C:69–77
Juozapaitis M, Aguiar Moreira E, Mena I, Giese S, Riegger D, Pohlmann A, Höper D, Zimmer G, Beer M, Garcia-Sastre A, Schwemmle M (2014) An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus. Nat Commun 5:4448
Koenig P, Hoffmann B, Depner KR, Reimann I, Teifke JP, Beer M (2007) Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine. Vet Microbiol 120:343–351
Koenig P, Lange E, Reimann I, Beer M (2007) CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against classical swine fever virus (CSFV). Vaccine 25:3391–3399
Lee YM, Tscherne DM, Yun SI, Frolov I, Rice CM (2005) Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication. J Virol 79:3231–3242
Leifer I, Depner K, Blome S, Le Potier MF, Le Dimna M, Beer M, Hoffmann B (2009) Differentiation of C-strain “Riems” or CP7_E2alf vaccinated animals from animals infected by classical swine fever virus field strains using real-time RT-PCR. J Virol Methods 158:114–122
Leifer I, Lange E, Reimann I, Blome S, Juanola S, Duran JP, Beer M (2009) Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization. Vaccine 27:6522–6529
Meyers G, Rümenapf T, Thiel HJ (1989) Ubiquitin in a togavirus. Nature 341:491
Reimann I, Depner K, Trapp S, Beer M (2004) An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 322:143–157
Tignon M, Kulcsar G, Haegeman A, Barna T, Fabian K, Levai R, Van der Stede Y, Farsang A, Vrancken R, Belak K, Koenen F (2010) Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs. Vet Microbiol 142:59–68
van Oirschot JT (2003) Vaccinology of classical swine fever: from lab to field. Vet Microbiol 96:367–384
van Oirschot JT (2003) Emergency vaccination against classical swine fever. Dev Biol (Basel) 114:259–267
Vanderhallen H, Mittelholzer C, Hofmann MA, Koenen F (1999) Classical swine fever virus is genetically stable in vitro and in vivo. Arch Virol 144:1669–1677
Weber MN, Streck AF, Silveira S, Mosena AC, Silva MS, Canal CW (2015) Homologous recombination in pestiviruses: identification of three putative novel events between different subtypes/genogroups. Infect Genet Evol 30:219–224
Xia H, Harimoorthy R, Vijayaraghavan B, Blome S, Widen F, Beer M, Belak S, Liu L (2015) Differentiation of classical swine fever virus infection from CP7_E2alf marker vaccination by a multiplex microsphere immunoassay. Clin Vaccine Immunol 22:65–71
Acknowledgments
The authors would like to thank Patrick Zitzow, Ulrike Kleinert and Kristin Trippler for the excellent laboratory work. The research project leading to these results has received funding through the vaccine manufacturer, Zoetis, and through the European Union’s Seventh Framework Program under grant agreement no. 289364 (RAPIDIA-Field).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Goller, K.V., Dräger, C., Höper, D. et al. Classical swine fever virus marker vaccine strain CP7_E2alf: genetic stability in vitro and in vivo . Arch Virol 160, 3121–3125 (2015). https://doi.org/10.1007/s00705-015-2611-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-015-2611-z